These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
364 related items for PubMed ID: 24446400
21. Effects of stage and number of tumours on prognosis of dogs with cutaneous mast cell tumours. Murphy S, Sparkes AH, Blunden AS, Brearley MJ, Smith KC. Vet Rec; 2006 Mar 04; 158(9):287-91. PubMed ID: 16517820 [Abstract] [Full Text] [Related]
22. Ultrasound-guided cytology of spleen and liver: a prognostic tool in canine cutaneous mast cell tumor. Stefanello D, Valenti P, Faverzani S, Bronzo V, Fiorbianco V, Pinto da Cunha N, Romussi S, Cantatore M, Caniatti M. J Vet Intern Med; 2009 Mar 04; 23(5):1051-7. PubMed ID: 19656285 [Abstract] [Full Text] [Related]
24. Evaluation of surgical margins required for complete excision of cutaneous mast cell tumors in dogs. Simpson AM, Ludwig LL, Newman SJ, Bergman PJ, Hottinger HA, Patnaik AK. J Am Vet Med Assoc; 2004 Jan 15; 224(2):236-40. PubMed ID: 14736068 [Abstract] [Full Text] [Related]
27. Clinical outcome of dogs with grade-II mast cell tumors treated with surgery alone: 55 cases (1996-1999). Séguin B, Leibman NF, Bregazzi VS, Ogilvie GK, Powers BE, Dernell WS, Fettman MJ, Withrow SJ. J Am Vet Med Assoc; 2001 Apr 01; 218(7):1120-3. PubMed ID: 11318363 [Abstract] [Full Text] [Related]
28. Metastatic mast cell tumour in a dog presenting with spinal pain. Cooper MA, Bennett PF, Laverty PH. Aust Vet J; 2009 Apr 01; 87(4):157-9. PubMed ID: 19335472 [Abstract] [Full Text] [Related]
29. Validation of the prognostic value of histopathological grading or c-kit mutation in canine cutaneous mast cell tumours: a retrospective cohort study. Takeuchi Y, Fujino Y, Watanabe M, Takahashi M, Nakagawa T, Takeuchi A, Bonkobara M, Kobayashi T, Ohno K, Uchida K, Asano K, Nishimura R, Nakayama H, Sugano S, Ohashi Y, Tsujimoto H. Vet J; 2013 Jun 01; 196(3):492-8. PubMed ID: 23384436 [Abstract] [Full Text] [Related]
30. Principles of treatment for mast cell tumors. Govier SM. Clin Tech Small Anim Pract; 2003 May 01; 18(2):103-6. PubMed ID: 12831070 [Abstract] [Full Text] [Related]
31. Biologic behavior and prognostic factors for mast cell tumors of the canine muzzle: 24 cases (1990-2001). Gieger TL, Théon AP, Werner JA, McEntee MC, Rassnick KM, DeCock HE. J Vet Intern Med; 2003 May 01; 17(5):687-92. PubMed ID: 14529136 [Abstract] [Full Text] [Related]
33. Cytological lymph node evaluation in dogs with mast cell tumours: association with grade and survival. Krick EL, Billings AP, Shofer FS, Watanabe S, Sorenmo KU. Vet Comp Oncol; 2009 Jun 01; 7(2):130-8. PubMed ID: 19453367 [Abstract] [Full Text] [Related]
38. Variation among pathologists in histologic grading of canine cutaneous mast cell tumors. Northrup NC, Harmon BG, Gieger TL, Brown CA, Carmichael KP, Garcia A, Latimer KS, Munday JS, Rakich PM, Richey LJ, Stedman NL, Cheng AL, Howerth EW. J Vet Diagn Invest; 2005 May 01; 17(3):245-8. PubMed ID: 15945380 [Abstract] [Full Text] [Related]
39. Correlation of ultrasound findings, liver and spleen cytology, and prognosis in the clinical staging of high metastatic risk canine mast cell tumors. Book AP, Fidel J, Wills T, Bryan J, Sellon R, Mattoon J. Vet Radiol Ultrasound; 2011 May 01; 52(5):548-54. PubMed ID: 21689203 [Abstract] [Full Text] [Related]